Regulation (EU) 2022/139
Commission Delegated Regulation (EU) 2022/139 of 16 November 2021 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the management, storage and replacement of stocks of the Union antigen, vaccine and diagnostic reagent banks and the biosecurity, biosafety and bio-containment requirements for the operation of those banks (Text with EEA relevance)
In forceTyperegulationDate16 Nov 2021Since2 Nov 2022Articles12Versions held49Cited by4 documents
- 1Subject matter and scope
- 2Definitions
- 3Rules on the contracts with manufacturers required for the management of the Union antigen, vaccine and diag
- 4Framework supply contracts for the vaccines and diagnostic reagents
- 5The management of the Union diagnostic reagent banks through grants awarded to European Union reference labo
- 6Conditions for the supply and storage of antigens, vaccines and diagnostic reagents
- 7Principles of selecting strains and variations of antigens, vaccines and diagnostic reagents
- 8Destruction and safe disposal of antigens, vaccines and diagnostic reagents
- 9Buy-back of the antigens for which the validity period has expired
- 10Biosecurity, biosafety and bio-containment requirements for the operation of the Union antigen, vaccine and
- 11Transitional measures
- 12Entry into force and application
- 1 ANNEX I CONDITIONS FOR THE SUPPLY AND STORAGE OF ANTIGENS, VACCINES AND DIAGNOSTIC REAGENTS AS REFERRED TO I
- 2 ANNEX II ADDITIONAL CONDITIONS FOR THE SUPPLY AND STORAGE OF CONCENTRATED INACTIVATED ANTIGENS OF THE FOOT A
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).